Smith & Nephew shares rise after the medical products giant posts better-then-expected results for the 4th quarter and full year, as the company says it plans to lay off 7% of its global workforce.
Smith & Nephew (NYSE:SNN) is up about 4% on Wall Street this morning after reporting stronger-than-expected results for the 4th quarter and full year.
The British medical products giant posted profits of $279 million, or 16 cents per share, on sales of $1.12 billion for the 3 months ended Dec. 31, 2011. That's a 3.7% addition to the top line, although profits were flat at a 0.4% gain, compared with profits of $278 million, or 21 cents per share, on sales of $1.07 billion during the same period in 2010.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...